文献速递肾小球疾病

血清PLA2R抗体阳性但肾活检PLA2R染色阴性的膜性肾病

Seropositive PLA2R-associated membranous nephropathy but biopsy-negative PLA2R staining.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

本研究纳入229例活检证实的PLA2R相关膜性肾病患者,血清PLA2R抗体均阳性,按肾组织冷冻免疫荧光PLA2R抗原沉积分为双阳性和血清阳性/组织阴性两组。结果显示8.3%患者组织阴性,但石蜡免疫组化可检出沉积;该组血清抗体更高、蛋白尿更多、血白蛋白更低、慢性病变更重。

要点

  • 血清PLA2R抗体阳性但肾组织冷冻免疫荧光PLA2R阴性的患者占8.3%。
  • 该组患者血清抗体水平更高、蛋白尿更重、血白蛋白更低、慢性病理病变更明显。
  • 石蜡免疫组化可替代冷冻免疫荧光检测肾组织PLA2R沉积。

核心结论

  • 血清PLA2R抗体阳性但冷冻免疫荧光肾组织PLA2R阴性的膜性肾病患者,血清抗体水平更高且临床病理表现更差。
  • 石蜡免疫组化可作为揭示肾小球PLA2R沉积的替代技术。

研究设计与样本

  • 本研究纳入229例活检证实的血清PLA2R抗体阳性的PLA2R相关膜性肾病患者。
  • 血清抗体用酶联免疫吸附试验检测,肾组织PLA2R抗原用冷冻免疫荧光检测,分组比较临床病理特征。
  • 19例血清阳性/组织阴性患者的PLA2R抗原用石蜡免疫组化验证。

主要发现

  • 229例中210例(91.70%)组织PLA2R抗原阳性,19例(8.3%)组织阴性。
  • 19例组织阴性患者石蜡免疫组化均显示PLA2R沉积阳性。
  • 与双阳性组相比,组织阴性组血清PLA2R抗体更高(P=0.004)、蛋白尿更多(P=0.008)、血清白蛋白更低(P=0.019)。
  • 组织阴性组慢性病理病变更突出:肾小球硬化评分(P=0.025)、间质纤维化评分(P=0.016)、肾小管萎缩评分(P=0.010)、总慢性化评分(P=0.010)更高,更常伴局灶节段性肾小球硬化(P=0.014)。
  • 较高血清抗体水平与总慢性化评分相关(每100 RU/mL的比值比1.16,95%置信区间1.01-1.33,P=0.033)。

临床怎么用

  • 对血清PLA2R抗体阳性但冷冻免疫荧光组织阴性的膜性肾病患者,应警惕其临床病理表现更重。
  • 石蜡免疫组化可用于验证肾组织PLA2R沉积,避免漏诊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Serum phospholipase A2 receptor (PLA2R) antibody (SAb) and glomerular deposits of PLA2R antigen (GAg) have been tested widely in idiopathic membranous nephropathy (MN). Recently, we noticed a special form of PLA2R-associated MN with positive circulating PLA2R antibody but negative PLA2R deposits in the glomeruli by immunofluorescence on frozen tissue (IF-F). The significance of this form of PLA2R-associated MN is yet to be elucidated. This study aimed to explore the clinicopathological features of these PLA2R-associated MN patients. METHODS: This study enrolled 229 biopsy-proven PLA2R-associated MN patients with SAb+. SAb was measured by enzyme-linked immunosorbent assay, and GAg was detected by IF-F. These patients were divided into SAb+/GAg+ and SAb+/GAg- groups. Clinicopathological characteristics of SAb+/GAg+ and SAb+/GAg- PLA2R-associated MN patients were compared. PLA2R antigens of 19 SAb+/GAg- PLA2R-associated MN patients were verified by immunohistochemistry on paraffin tissue (IHC-P). RESULTS: Among 229 SAb+ PLA2R-associated MN patients, 210 (91.70%) were GAg+ and 19 (8.3%) were GAg-. These 19 SAb+/GAg- PLA2R-associated MN patients presented positive PLA2R deposits by IHC-P. Compared with SAb+/GAg+ PLA2R-associated MN patients, SAb+/GAg- PLA2R-associated MN patients had higher levels of serum PLA2R antibody (P = 0.004), increased proteinuria (P = 0.008), lower serum albumin (P = 0.019), more prominent chronic pathological lesions in terms of glomerulosclerosis score (P = 0.025), interstitial fibrosis score (P = 0.016), tubular atrophy score (P = 0.010) and total renal chronicity score (P = 0.010), and were more likely to be accompanied by focal segmental glomerulosclerosis (P = 0.014). Higher SAb level was associated with the total renal chronicity score (odds ratio per 100 RU/mL, 1.16; 95% confidence interval 1.01-1.33; P = 0.033). CONCLUSIONS: PLA2R-associated MN patients with seropositive PLA2R antibody but negative PLA2R deposits in the glomeruli by IF-F have higher levels of SAb and worse clinicopathological manifestations compared with their double-positive counterparts. IHC-P can be an alternative technique to reveal PLA2R glomerular deposits.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Luo J, Zhang W, Su C, et al. Seropositive PLA2R-associated membranous nephropathy but biopsy-negative PLA2R staining. Nephrol Dial Transplant. 2021. PMID: 33236093. doi:10.1093/ndt/gfaa239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。